- Home
- PNRG vs CCCC Comparison
PNRG vs CCCC Comparison
Compare PNRG & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNRG
- CCCC
- Stock Information
- Founded
- PNRG 1973
- CCCC 2015
- Country
- PNRG United States
- CCCC United States
- Employees
- PNRG N/A
- CCCC N/A
- Industry
- PNRG Oil & Gas Production
- CCCC Biotechnology: Pharmaceutical Preparations
- Sector
- PNRG Energy
- CCCC Health Care
- Exchange
- PNRG Nasdaq
- CCCC Nasdaq
- Market Cap
- PNRG 355.8M
- CCCC 396.0M
- IPO Year
- PNRG N/A
- CCCC 2020
- Fundamental
- Price
- PNRG $213.37
- CCCC $3.94
- Analyst Decision
- PNRG
- CCCC Buy
- Analyst Count
- PNRG 0
- CCCC 6
- Target Price
- PNRG N/A
- CCCC $10.67
- AVG Volume (30 Days)
- PNRG 15.5K
- CCCC 2.0M
- Earning Date
- PNRG 11-14-2024
- CCCC 02-20-2025
- Dividend Yield
- PNRG N/A
- CCCC N/A
- EPS Growth
- PNRG 71.12
- CCCC N/A
- EPS
- PNRG 23.14
- CCCC N/A
- Revenue
- PNRG $210,064,000.00
- CCCC $33,668,000.00
- Revenue This Year
- PNRG N/A
- CCCC $75.79
- Revenue Next Year
- PNRG N/A
- CCCC N/A
- P/E Ratio
- PNRG $9.22
- CCCC N/A
- Revenue Growth
- PNRG 88.03
- CCCC 65.45
- 52 Week Low
- PNRG $92.40
- CCCC $3.38
- 52 Week High
- PNRG $243.49
- CCCC $11.88
- Technical
- Relative Strength Index (RSI)
- PNRG 56.39
- CCCC 48.85
- Support Level
- PNRG $200.00
- CCCC $3.81
- Resistance Level
- PNRG $218.50
- CCCC $4.07
- Average True Range (ATR)
- PNRG 14.12
- CCCC 0.28
- MACD
- PNRG -0.09
- CCCC 0.05
- Stochastic Oscillator
- PNRG 35.27
- CCCC 63.64
About PNRG PrimeEnergy Resources Corporation
PrimeEnergy Resources Corp is an independent oil and natural gas company that is engaged in acquiring, developing, and producing oil and natural gas. It owns producing and non-producing properties located in Texas and Oklahoma. The company's business activities include development and exploratory drilling and provide well servicing support operations for many of the onshore oil and gas wells through its subsidiaries. It is also active in the acquisition of producing oil and gas properties through joint ventures with industry partners.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.